Latest Insider Transactions at Ab Cellera Biologics Inc. (ABCL)
This section provides a real-time view of insider transactions for Ab Cellera Biologics Inc. (ABCL). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of AbCellera Biologics Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of AbCellera Biologics Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 20
2024
|
Carl L. G. Hansen Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
56,125
+6.25%
|
$112,250
$2.7 P/Share
|
|
Aug 29
2024
|
Thermopylae Holdings Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
283,516
+0.5%
|
$567,032
$2.61 P/Share
|
|
Jun 21
2024
|
Veronique Lecault Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
83,334
+3.78%
|
$0
$0.19 P/Share
|
|
May 31
2024
|
Carl L. G. Hansen Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
56,125
+6.67%
|
$112,250
$2.7 P/Share
|
|
Feb 26
2024
|
Carl L. G. Hansen Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
56,125
+7.14%
|
$112,250
$2.7 P/Share
|
|
Dec 19
2023
|
Thermopylae Holdings Ltd. > 10% Shareholder |
SELL
Bona fide gift
|
Direct |
210,000
-0.37%
|
-
|
|
Nov 23
2023
|
Carl L. G. Hansen Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
56,125
+7.69%
|
$112,250
$2.7 P/Share
|
|
Nov 08
2023
|
John S. Montalbano Director |
BUY
Open market or private purchase
|
Direct |
10,000
+10.42%
|
$40,000
$4.46 P/Share
|
|
Nov 06
2023
|
John S. Montalbano Director |
BUY
Open market or private purchase
|
Direct |
20,000
+20.83%
|
$80,000
$4.64 P/Share
|
|
Sep 22
2023
|
Michael R Hayden Director |
BUY
Open market or private purchase
|
Indirect |
20,000
+1.49%
|
$80,000
$4.91 P/Share
|
|
Sep 12
2023
|
Veronique Lecault Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
20,000
+0.97%
|
$100,000
$5.19 P/Share
|
|
Aug 24
2023
|
Carl L. G. Hansen Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
56,125
+8.33%
|
$112,250
$2.7 P/Share
|
|
Aug 08
2023
|
Michael R Hayden Director |
BUY
Open market or private purchase
|
Indirect |
30,000
+2.25%
|
$150,000
$5.9 P/Share
|
|
May 26
2023
|
Carl L. G. Hansen Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
56,125
+9.09%
|
$112,250
$2.7 P/Share
|
|
May 26
2023
|
Andrew Booth Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
14,500
+8.66%
|
$87,000
$6.85 P/Share
|
|
May 26
2023
|
Thermopylae Holdings Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
153,000
+0.27%
|
$918,000
$6.52 P/Share
|
|
May 05
2023
|
Veronique Lecault Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
250,000
+11.01%
|
$0
$0.19 P/Share
|
|
Feb 22
2023
|
Carl L. G. Hansen Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
56,125
+10.0%
|
$112,250
$2.7 P/Share
|
|
Dec 20
2022
|
Andrew Booth Chief Financial Officer |
SELL
Bona fide gift
|
Direct |
50,000
-26.53%
|
-
|
|
Dec 20
2022
|
Andrew Booth Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+20.96%
|
$0
$0.19 P/Share
|
|
Dec 16
2022
|
Thermopylae Holdings Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
85,102
+0.15%
|
$851,020
$10.1 P/Share
|
|
Nov 18
2022
|
Carl L. G. Hansen Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
56,125
+11.11%
|
$112,250
$2.7 P/Share
|
|
Oct 31
2022
|
Thermopylae Holdings Ltd. > 10% Shareholder |
SELL
Bona fide gift
|
Direct |
70,000
-0.13%
|
-
|
|
Aug 19
2022
|
Thermopylae Holdings Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
200,000
+0.36%
|
$2,200,000
$11.46 P/Share
|
|
Aug 18
2022
|
Carl L. G. Hansen Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
56,125
+12.5%
|
$112,250
$2.7 P/Share
|
|
Jun 14
2022
|
Thermopylae Holdings Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
9,173
+0.02%
|
$73,384
$8.05 P/Share
|
|
Jun 13
2022
|
Thermopylae Holdings Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
54,915
+0.1%
|
$439,320
$8.03 P/Share
|
|
Jun 06
2022
|
Thermopylae Holdings Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
64,545
+0.12%
|
$451,815
$7.5 P/Share
|
|
May 18
2022
|
Carl L. G. Hansen Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
56,125
+14.29%
|
$112,250
$2.7 P/Share
|
|
May 16
2022
|
Veronique Lecault Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
200,000
+10.15%
|
$1,200,000
$6.34 P/Share
|
|
May 13
2022
|
Thermopylae Holdings Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
300,000
+0.54%
|
$2,100,000
$7.26 P/Share
|
|
May 12
2022
|
Andrew Booth Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
85,000
+38.03%
|
$425,000
$5.79 P/Share
|
|
May 12
2022
|
Thermopylae Holdings Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,408,468
+2.49%
|
$8,450,808
$6.41 P/Share
|
|
Mar 04
2022
|
John S. Montalbano Director |
BUY
Open market or private purchase
|
Direct |
10,000
+15.15%
|
$80,000
$8.54 P/Share
|
|
Mar 01
2022
|
John S. Montalbano Director |
BUY
Open market or private purchase
|
Direct |
20,000
+30.3%
|
$180,000
$9.05 P/Share
|
|
Feb 28
2022
|
Veronique Lecault Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
230,789
+12.82%
|
$1,846,312
$8.66 P/Share
|
|
Feb 22
2022
|
Carl L. G. Hansen Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
56,125
+16.67%
|
$112,250
$2.7 P/Share
|
|
Dec 10
2021
|
Andrew Booth Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
500,000
+47.46%
|
$0
$0.32 P/Share
|
|
Dec 08
2021
|
Veronique Lecault Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
250,000
+13.59%
|
$0
$0.19 P/Share
|
|
Dec 03
2021
|
Andrew Lo Director |
BUY
Open market or private purchase
|
Direct |
86,938
+50.0%
|
$1,217,132
$14.02 P/Share
|
|
Nov 30
2021
|
Veronique Lecault Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
83,333
+5.53%
|
$1,166,662
$14.96 P/Share
|
|
Nov 18
2021
|
Carl L. G. Hansen Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
224,500
+50.0%
|
$3,367,500
$15.03 P/Share
|
|
Nov 11
2021
|
Thermopylae Holdings Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
202,960
+0.36%
|
$2,841,440
$14.76 P/Share
|
|
Nov 11
2021
|
Andrew Booth Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect |
14,000
+9.66%
|
$196,000
$14.61 P/Share
|
|
Nov 11
2021
|
Andrew Booth Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
53,500
+50.0%
|
$749,000
$14.74 P/Share
|
|
Sep 13
2021
|
Michael R Hayden Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
270,000
+17.49%
|
$4,590,000
$17.73 P/Share
|
|
Sep 01
2021
|
Ester Falconer Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
875,000
+50.0%
|
$14,000,000
$16.89 P/Share
|
|
Sep 01
2021
|
John Hamer Director |
SELL
Open market or private sale
|
Direct |
137,351
-51.59%
|
$2,197,616
$16.93 P/Share
|
|
Aug 31
2021
|
John Hamer Director |
SELL
Open market or private sale
|
Direct |
162,649
-37.93%
|
$2,602,384
$16.95 P/Share
|
|
Aug 16
2021
|
John S. Montalbano Director |
BUY
Open market or private purchase
|
Direct |
6,000
+18.75%
|
$102,000
$17.23 P/Share
|